This company has been acquired
Salud financiera de hoja de balance de LogicBio Therapeutics
Salud financiera controles de criterios 5/6
Información clave
37.7%
Ratio deuda-patrimonio
US$5.93m
Deuda
| Ratio de cobertura de intereses | n/a |
| Efectivo | US$30.78m |
| Patrimonio | US$15.74m |
| Total pasivo | US$22.86m |
| Activos totales | US$38.60m |
Actualizaciones recientes sobre salud financiera
Is LogicBio Therapeutics (NASDAQ:LOGC) Weighed On By Its Debt Load?
Jan 11
Does LogicBio Therapeutics (NASDAQ:LOGC) Have A Healthy Balance Sheet?
Aug 18Is LogicBio Therapeutics (NASDAQ:LOGC) Using Debt Sensibly?
Apr 12Recent updates
LogicBio jumps 648% on buyout deal with AstraZeneca unit Alexion
Oct 03Bullish: Analysts Just Made A Notable Upgrade To Their LogicBio Therapeutics, Inc. (NASDAQ:LOGC) Forecasts
Aug 20LogicBio Therapeutics, Inc. (NASDAQ:LOGC) Just Reported Second-Quarter Earnings And Analysts Are Lifting Their Estimates
Aug 18LogicBio GAAP EPS of -$0.15, revenue of $3.2M
Aug 15Is LogicBio Therapeutics (NASDAQ:LOGC) Weighed On By Its Debt Load?
Jan 11Does LogicBio Therapeutics (NASDAQ:LOGC) Have A Healthy Balance Sheet?
Aug 18LogicBio EPS misses by $0.06, beats on revenue
May 10LogicBio announces agreements with CANbridge Pharma and Daiichi Sankyo
Apr 27Is LogicBio Therapeutics (NASDAQ:LOGC) Using Debt Sensibly?
Apr 12Is LogicBio Therapeutics, Inc. (NASDAQ:LOGC) Popular Amongst Insiders?
Mar 08The LogicBio Therapeutics (NASDAQ:LOGC) Share Price Has Gained 12% And Shareholders Are Hoping For More
Jan 15LogicBio extends collaboration with Children's Medical Research Institute
Jan 07LogicBio Therapeutics names new CFO
Dec 22Looking In On LogicBio
Nov 17LogicBio reports Q3 results
Nov 09Análisis de la situación financiera
Pasivos a corto plazo: LOGC's short term assets ($32.8M) exceed its short term liabilities ($16.4M).
Pasivo a largo plazo: LOGC's short term assets ($32.8M) exceed its long term liabilities ($6.4M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: LOGC has more cash than its total debt.
Reducción de la deuda: Insufficient data to determine if LOGC's debt to equity ratio has reduced over the past 5 years.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: LOGC has sufficient cash runway for more than a year based on its current free cash flow.
Pronóstico de cash runway: LOGC has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 15.8% each year.